Results 101 to 110 of about 2,190 (132)

Do de novo acute myeloid leukemias with normal cytogenetics involve two main prognostic categories distinguished by the presence of erythroblastic and/or megakaryocytic dysplasia?

Neoplasma, 2000
De novo acute myeloid leukemias (AML) patients with normal cytogenetics represent a standard risk cytogenetic group. Erythroblastic and/or megakaryocytic dysplasia (EMD) in diagnostic bone marrow smears of 28 consecutive AML patients with a normal karyotype was studied.
P, Lemez, J, Gáliková, T, Haas
openaire   +1 more source

PREreview of "Loss of erythroblasts in acute myeloid leukemia causes iron redistribution with clinical implications"

This Zenodo record is a permanently preserved version of a PREreview. You can view the complete PREreview at https://prereview.org/reviews/21282948. Major issues 1. Reliance on a single AML mouse model The study relies almost exclusively on the MLL-AF9 syngeneic AML model. Given the marked biological heterogeneity of AML, validation in additional
openaire   +1 more source

[Patients older than 80 years with de novo acute myeloid leukemias without erythroblastic and/or megakaryocytic dysplasia achieve complete remission and longer survival after classical chemotherapy 3 + 7].

Vnitrni lekarstvi, 2010
Chemotherapy in most patients with AML over 80 years of age is not recommended because their median survival is about 1 month. The aim of our study was to identify patients in this age group who might achieve complete remission with standard dose chemotherapy. We report 9 consecutive patients with de novo AML diagnosed and treated in 1992-2008.
P, Lemez, J, Gáliková, K, Michalová, D, Dvoráková, A, MacWhannell, Z, Zemanová, J, Stejskal   +6 more
openaire   +1 more source

Isochromosome 11q in acute erythroblastic leukemia

Leukemia Research, 1992
openaire   +2 more sources

Acute leukemia in adults: recent developments in diagnosis and treatment

Ca-A Cancer Journal for Clinicians, 1994
Richard Larson, S M Devine
exaly  

CIC‐Rearrangements in Pediatric Acute Erythroid Leukemia/Erythroblastic Sarcoma

Pediatric Blood & Cancer
Alexandra L. Chang‐Graham, Thien Nguyen, Jean Oak, Oscar Silva, Tanja A. Gruber   +4 more
openaire   +2 more sources

Treatment of Acute Leukemia:: Current Results, and Analysis of What We Can Do Now

Ca-A Cancer Journal for Clinicians, 1964
M P Sullivan, W W Sutow
exaly  

Immature erythroblasts in pleural effusion: an initial presentation of acute erythroid leukemia in a patient with a history of MDS

Blood
Zhihong Hu, Chi Young Ok
openaire   +2 more sources

Management of the Acute Leukemia Patient and Family

Ca-A Cancer Journal for Clinicians, 1965
S Farber
exaly  

Supportive Therapy in Acute Leukemia

Ca-A Cancer Journal for Clinicians, 1964
E J Freireich
exaly